Trump Signs Executive Order to Lower Prescription Drug Prices

Executive Order on Drug Pricing

• 🇺🇸 President Trump signed an executive order aimed at lowering prescription drug prices, calling it one of the most consequential in U.S. history.
• 🎯 The order targets price gouging and the practice of the U.S. subsidizing healthcare for foreign countries.

International Drug Price Disparities

• 💰 A key point is that other countries, particularly in the European Union, pay a small fraction of the price for the same drugs that Americans pay.
• 💡 An anecdote illustrates this: a friend paid $88 for a drug in London that cost $1,300 in New York, with the same drug manufactured in the same plant.
• 🌍 The U.S. will no longer tolerate being the sole subsidizer of research and development costs for drugs sold globally.

Most Favored Nation Pricing

• ⚖️ The U.S. will now aim to pay the lowest price paid for a drug in any other developed country, a principle termed Most Favored Nation pricing.
• 📉 This policy is expected to reduce prescription drug prices in America by 50% to 90%.
• 🤝 Big pharma will either comply voluntarily or face federal government intervention to ensure these price reductions.

Addressing Middlemen and Imports

• ✂️ The administration plans to cut out middlemen in the drug distribution chain to facilitate direct sales at the favored nation price.
• 📦 The U.S. market will also be opened to safe and legal imports of affordable drugs from other countries to further drive down prices.
• 📈 This initiative is presented as a way to bring fairness and significantly lower costs for American citizens, despite opposition from powerful lobbies.

Criticism of Past Policies and Democrats

• ⚠️ The order is contrasted with Joe Biden's approach, which is described as a failure that led to higher prices.
• 🚫 Democrats are criticized for protecting drug companies and fighting against efforts to lower prices.
• 📊 The economic impact is highlighted, with hundreds of billions of dollars in tariff money expected to come in, alongside significant savings in Medicare and Medicaid drug costs.